Shares of Compugen (CGEN) move up 6.9% in premarket trading after the firm announces that its...

|About: Compugen Ltd. (CGEN)|By:, SA News Editor

Shares of Compugen (CGEN) move up 6.9% in premarket trading after the firm announces that its CGEN-15001T cancer drug demonstrates "significant potential" for cancer immunotherapy. The firm says it ran studies using an antibody specifically recognizing CGEN-15001T.